# BiopharmaWatch

> BiopharmaWatch is a biotech investing intelligence platform providing real-time FDA & PDUFA calendars, clinical-trial data, probability-of-approval scores, insider trading, hedge-fund holdings, M&A target scores, and market-moving catalysts for 2,000+ biotech and pharmaceutical stocks. Data is aggregated from primary regulatory sources and updated daily.

BiopharmaWatch helps biotech investors track drug-approval dates, regulatory events, clinical readouts, and company fundamentals. A free tier covers core data; full datasets and proprietary scores are available to subscribers.

## Data sources & methodology

Aggregated and structured from primary sources, updated daily:
- FDA approvals & PDUFA dates - FDA.gov, Federal Register, company 8-K filings
- Clinical trials - ClinicalTrials.gov (NCT records)
- Insider transactions & institutional holdings - SEC EDGAR (Form 4, 13F)
- Financials & prices - company 10-K/10-Q filings and market data

Proprietary models: **Probability of Approval (PoA)** - Bayesian, base-rate-adjusted estimate per drug/indication; **M&A Target Scores** - acquisition-likelihood across the biotech universe; **risk-adjusted NPV (rNPV)** per pipeline asset.

## Core tools

- [FDA Calendar](https://www.biopharmawatch.com/fda-calendar): Upcoming FDA approval/PDUFA dates, advisory committee meetings, and decisions, with probability-of-approval scores.
- [PDUFA Calendar](https://www.biopharmawatch.com/PDUFA-calendar): FDA decision deadlines (Prescription Drug User Fee Act dates).
- [Company Screener](https://www.biopharmawatch.com/company-screener): Screen 2,000+ biotechs by clinical stage, market cap, therapeutic area, cash runway, and upcoming catalysts.
- [CatalystSync](https://www.biopharmawatch.com/catalyst-sync): Custom watchlists with real-time PDUFA / FDA / clinical-readout alerts.
- [Insider Trading Tracker](https://www.biopharmawatch.com/inside-trades): Real-time SEC Form 4 insider buys and sells.
- [Hedge Fund Holdings](https://www.biopharmawatch.com/hedgefunds): Quarterly 13F institutional positions in biotech.
- [Biotech Earnings Calendar](https://www.biopharmawatch.com/biotech-earnings-calendar): Earnings dates with EPS estimates.
- [Market Movers](https://www.biopharmawatch.com/market-movers): Daily gainers, losers, and unusual volume.
- [IPO & SEC Filings](https://www.biopharmawatch.com/ipo-sec): Upcoming biotech IPOs, S-1 filings, and lock-up expirations.
- [Conference Calendar](https://www.biopharmawatch.com/conference-calendar): Biotech conferences and medical meetings.
- [Biotech News](https://www.biopharmawatch.com/news): Catalyst-tagged biotech news feed.

## Proprietary intelligence

- [M&A Tracker](https://www.biopharmawatch.com/ma-tracker): Acquisition-target scores, deal analysis, and likely acquirers across biotech.
- [Modality Leaderboard](https://www.biopharmawatch.com/modality-leaderboard): Top biotechs ranked by drug modality (mAb, small molecule, gene therapy, ADC, RNAi, CAR-T).
- [Trial Monitor](https://www.biopharmawatch.com/trial-monitor): Real-time clinical-trial status changes.
- [Model Portfolios](https://www.biopharmawatch.com/model-portfolio): Quant biotech strategies and holdings.
- Company pages - per-ticker at `/company/{TICKER}`, e.g. [/company/MRNA](https://www.biopharmawatch.com/company/MRNA), [/company/VRTX](https://www.biopharmawatch.com/company/VRTX): pipeline, upcoming catalysts, PoA scores, financials, and ownership.
- [API](https://www.biopharmawatch.com/api-docs): Programmatic access to the catalyst, FDA, clinical-trial, and market datasets.

## Historical data

- [Historical FDA Calendar](https://www.biopharmawatch.com/historical-fda-calendar): Past FDA approval decisions and drug success rates.
- [Historical PDUFA](https://www.biopharmawatch.com/historical-pdufa-calendar): Search past PDUFA outcomes by ticker.

## Questions BiopharmaWatch answers

- When is the FDA decision (PDUFA date) for a given drug or company?
- What is the probability of approval for a specific drug or indication?
- Which biotech companies are likely acquisition targets?
- What insider buying or hedge-fund (13F) activity is happening in a stock?
- What upcoming catalysts (data readouts, FDA decisions) does a company have?

## Company

- [About](https://www.biopharmawatch.com/about): About BiopharmaWatch
- [Blog](https://www.biopharmawatch.com/blog): Biotech investing articles and analysis
- [Contact](https://www.biopharmawatch.com/contact-us): Get in touch

## Optional

- [Editorial Policy](https://www.biopharmawatch.com/editorial-policy): Editorial standards and data sourcing
- [Disclaimer](https://www.biopharmawatch.com/disclaimer): Investment disclaimer
- [Privacy Policy](https://www.biopharmawatch.com/privacy-policy): Privacy policy
- [Terms of Service](https://www.biopharmawatch.com/Terms-service): Terms of service